Chemed Net Total Equity Issued/Repurchased 2010-2025 | CHE

Chemed annual/quarterly net total equity issued/repurchased history and growth rate from 2010 to 2025. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
  • Chemed net total equity issued/repurchased for the quarter ending March 31, 2025 was $-0.017B, a 142.11% increase year-over-year.
  • Chemed net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.504B, a 745.82% decline year-over-year.
  • Chemed annual net total equity issued/repurchased for 2024 was $-0.314B, a 1360.44% decline from 2023.
  • Chemed annual net total equity issued/repurchased for 2023 was $0.025B, a 129.28% decline from 2022.
  • Chemed annual net total equity issued/repurchased for 2022 was $-0.085B, a 84.67% decline from 2021.
Chemed Annual Net Total Equity Issued/Repurchased
(Millions of US $)
2024 $-314
2023 $25
2022 $-85
2021 $-555
2020 $-151
2019 $-87
2018 $-154
2017 $-82
2016 $-103
2015 $-60
2014 $-96
2013 $-81
2012 $-52
2011 $-140
2010 $-104
2009 $-4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.151B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.479B 19.20
Encompass Health (EHC) United States $11.855B 25.13
DaVita (DVA) United States $10.870B 15.28
Elanco Animal Health (ELAN) United States $6.466B 13.85
Option Care Health (OPCH) United States $5.168B 23.04
RadNet (RDNT) United States $4.542B 288.24
Amedisys (AMED) United States $3.101B 20.86
LifeStance Health (LFST) United States $2.283B 0.00
Addus HomeCare (ADUS) United States $2.019B 22.17
Astrana Health (ASTH) United States $1.497B 37.08
U.S Physical Therapy (USPH) United States $1.173B 30.28
Aveanna Healthcare Holdings (AVAH) United States $1.143B 65.11
Pennant (PNTG) United States $1.005B 36.92
Atai Life Sciences (ATAI) Germany $0.282B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00